InsidersTradesSigma
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by ROBERTS JOHN A, Chairman & CEO. Insider active across 2 companies, notably Vyant Bio, Inc.. Cumulatively, 6 disclosures have been logged. Total volume traded: €102k. The latest transaction was filed on 24 November 2021 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
€8,9825,000 shares@ €1.796417.6% of flow
Common Stock, $0.0001 par value
SEC:0001493152-21-029828·
Ideal exit: 21 Aug 2022 (T+270)
€8,9825,000 shares@ €1.79648.8% of flow
Common Stock, $0.0001 par value
SEC:0001493152-21-029828:0·
Ideal exit: 21 Aug 2022 (T+270)
€21,35310,406 shares@ €2.05241.9% of flow
Common Stock, $0.0001 par value
SEC:0001493152-21-021244·
Ideal exit: 20 May 2022 (T+270)
€21,35310,406 shares@ €2.05221.0% of flow
Common Stock, $0.0001 par value
SEC:0001493152-21-021244:0·
Ideal exit: 20 May 2022 (T+270)
€20,5887,440 shares@ €2.767240.4% of flow
Common Stock, $0.0001 par value
SEC:0001493152-21-013101·
Ideal exit: 18 Feb 2022 (T+270)
€20,5887,440 shares@ €2.767220.2% of flow
Common Stock, $0.0001 par value
SEC:0001493152-21-013101:0·
Ideal exit: 18 Feb 2022 (T+270)
6 of 6 declarations
About ROBERTS JOHN A
John A. Roberts is the Chief Executive Officer of Vyant Bio, Inc. He leads the company's operations, focusing on business strategy and growth. His expertise in the biopharmaceutical sector is crucial in guiding Vyant in its development initiatives.
